|
Useful links about ATMPs
|
|
0
|
81
|
June 25, 2024
|
|
European Study on the Hospital Exemption out
|
|
0
|
22
|
August 15, 2025
|
|
Committee for Advanced Therapies (CAT) workshop on gene editing
|
|
0
|
17
|
July 28, 2025
|
|
Navigating the CRISPR/Cas9 Patent Maze
|
|
1
|
31
|
July 21, 2025
|
|
Advanced Therapies Europe | Event
|
|
0
|
15
|
July 15, 2025
|
|
TechTalk XL - Cell & Gene Therapies (Leiden)
|
|
0
|
26
|
June 18, 2025
|
|
How do clinical study requirements for ATMPs differ from others?
|
|
2
|
53
|
June 13, 2025
|
|
First FDA platform technology designation, how to move from progress for one to potential for many?
|
|
0
|
7
|
June 6, 2025
|
|
Quality by Design for ATMPs?
|
|
0
|
22
|
May 30, 2025
|
|
Platforms technologies: CBG Science Day meets first In Vivo base editor case
|
|
0
|
13
|
May 19, 2025
|
|
Decentralized Cell Therapy Manufacturing Webinar
|
|
0
|
19
|
May 12, 2025
|
|
How to manage the long-term follow-up requirements for ATMPs?
|
|
1
|
41
|
May 2, 2025
|
|
Gene Therapy Trial Browser
|
|
0
|
26
|
May 2, 2025
|
|
ADVANCE 5-day Summer School on Cell and Gene Therapies
|
|
0
|
18
|
April 14, 2025
|
|
Guidebook for the development of ATMPs
|
|
0
|
40
|
January 8, 2025
|
|
FAST ATMP webinar part 3 - Market authorization, hospital exemptions, reimbursement
|
|
2
|
45
|
April 1, 2025
|
|
FAST ATMP webinar part 2 - Non-clinical development, clinical development, Regulation and legislation
|
|
2
|
51
|
April 1, 2025
|
|
FAST ATMP Webinar part 1 - Patient participation, classification of ATMPs, product development
|
|
2
|
111
|
April 1, 2025
|
|
Is there a guidance document for ATMPs during process changes or manufacturing scale-up?
|
|
1
|
34
|
March 19, 2025
|
|
Is there a format or guidance document for writing a product development plan and IMPD specifically for ATMPs
|
|
3
|
42
|
March 14, 2025
|
|
DARE-NL Annual Consortium Meeting
|
|
0
|
15
|
March 14, 2025
|
|
Online information about Gene Therapy for monogenic diseases - for patients
|
|
0
|
20
|
March 11, 2025
|
|
How can the lack of formal documentation in patient involvement activities be addressed?
|
|
4
|
93
|
March 11, 2025
|
|
Dutch ATMP summit
|
|
0
|
29
|
December 12, 2024
|
|
CAT template examples
|
|
2
|
70
|
February 14, 2025
|
|
Exploring Academic ATMP Development: Insights from Belgium & Comparisons with the Netherlands
|
|
0
|
18
|
February 14, 2025
|
|
EU HTA regulation impact and ATMP market access?
|
|
0
|
25
|
February 5, 2025
|
|
Regulatory expectations for potency assays
|
|
0
|
26
|
January 23, 2025
|
|
Patient limits for Hospital Exemption in the Netherlands
|
|
2
|
75
|
January 21, 2025
|
|
Advanced Therapies 2025 - London
|
|
0
|
22
|
December 12, 2024
|